IART vs SGP: stock comparison and AI forecast
Integra Lifesciences Holdings Corp (IART) and Spyglass Pharma, Inc. (SGP) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
IART Integra Lifesciences Holdings Corp
- Price
- $13.61 +27.8% · 6M
- Market Cap
- $1.06B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SGP Spyglass Pharma, Inc.
- Price
- $33.64 +37.8% · 6M
- Market Cap
- $1.13B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- IART and SGP have similar market capitalizations ($1.06B and $1.13B).
- Over the last six months SGP returned +37.8% and IART +27.8%.
- IART carries 2.29 times debt per unit of equity, against 0.05 times for SGP.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | IART | SGP |
|---|---|---|
| Market Cap | $1.06B | $1.13B |
| P/B Ratio | 0.99x | 4.84x |
| EPS | $-0.17 | – |
| Book Value/Share | $13.71 | $6.95 |
| Revenue/Share | $21.30 | – |
| FCF/Share | $1.10 | – |
Profitability & Margins
| Metric | IART | SGP |
|---|---|---|
| ROIC | 2.3% | – |
| Gross Margin | 52.4% | – |
| Operating Margin | 4.4% | – |
| EBT Margin | 1.4% | – |
| Tax Rate | 41.7% | – |
Financial Health
| Metric | IART | SGP |
|---|---|---|
| Current Ratio | 3.62x | 25.06x |
| Quick Ratio | 2.21x | – |
| D/E Ratio | 2.29x | 0.05x |
| Financial Leverage | 3.29x | 1.05x |
| Interest Coverage | 0.3x | – |
| Working Capital | $861M | $227M |
Cash Flow
| Metric | IART | SGP |
|---|---|---|
| Operating Cash Flow | $140M | – |
| Free Cash Flow | $86M | – |
| Capital Spending | -$55M | – |
| OCF Growth YoY | 57.2% | – |
| FCF/Sales | 5.2% | – |
| CapEx/Sales | 3.3% | – |
Operational Efficiency
| Metric | IART | SGP |
|---|---|---|
| Asset Turnover | 0.47x | – |
| Receivables Turnover | 6.7x | – |
| Inventory Turnover | 1.7x | – |
| Fixed Assets Turnover | 3.8x | – |
| Days Sales Outstanding | 55 days | – |
| Days Inventory | 215 days | – |
Income Statement
| Metric | IART | SGP |
|---|---|---|
| Total Revenue | $1.66B | – |
| Operating Income | $73M | – |
| R&D Expense | $94M | – |
| SG&A Expense | $685M | – |
| Cost of Goods Sold | $789M | – |
Dividend & Shareholder Information
| Metric | IART | SGP |
|---|---|---|
| Shares Outstanding | 78M | 33M |
IART vs SGP: stock comparison and AI forecast
Which is bigger, IART or SGP?
IART and SGP have similar market capitalizations ($1.06B and $1.13B).
Which stock performed better over the last six months, IART or SGP?
Over the last six months SGP returned +37.8% and IART +27.8%.
Which one does Intratio's AI model rank higher, IART or SGP?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.